127 related articles for article (PubMed ID: 9802399)
1. Neuropeptide Y receptors involved in calcium channel regulation in PC12 cells.
McCullough LA; Egan TM; Westfall TC
Regul Pept; 1998 Sep; 75-76():101-7. PubMed ID: 9802399
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of neuropeptide Y, peptide YY, and pancreatic polypeptide inhibition of identified green fluorescent protein-expressing GABA neurons in the hypothalamic neuroendocrine arcuate nucleus.
Acuna-Goycolea C; Tamamaki N; Yanagawa Y; Obata K; van den Pol AN
J Neurosci; 2005 Aug; 25(32):7406-19. PubMed ID: 16093392
[TBL] [Abstract][Full Text] [Related]
3. Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus.
Silva AP; Carvalho AP; Carvalho CM; Malva JO
Neuropharmacology; 2003 Feb; 44(2):282-92. PubMed ID: 12623227
[TBL] [Abstract][Full Text] [Related]
4. Is there really an NPY Y3 receptor?
Lee CC; Miller RJ
Regul Pept; 1998 Sep; 75-76():71-8. PubMed ID: 9802395
[TBL] [Abstract][Full Text] [Related]
5. Peripheral modulation of duodenal and colonic motility and arterial pressure by neuropeptide Y, neuropeptide Y fragment 13-36, peptide YY, and pancreatic polypeptide in rats: cholinergic mechanisms.
Wager-Pagé SA; Raizada E; Veale W; Davison JS
Can J Physiol Pharmacol; 1993; 71(10-11):768-75. PubMed ID: 8143235
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the receptor response for the neuropeptide Y-evoked suppression of parasympathetically-mediated contractions in the guinea pig trachea.
Grundemar L
Regul Pept; 1997 Aug; 71(2):97-101. PubMed ID: 9416991
[TBL] [Abstract][Full Text] [Related]
7. Effects of differentiation on neuropeptide-Y receptors and responses in rat pheochromocytoma cells.
DiMaggio DA; Farah JM; Westfall TC
Endocrinology; 1994 Feb; 134(2):719-27. PubMed ID: 8299567
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of synaptic transmission by neuropeptide Y in rat hippocampal area CA1: modulation of presynaptic Ca2+ entry.
Qian J; Colmers WF; Saggau P
J Neurosci; 1997 Nov; 17(21):8169-77. PubMed ID: 9334392
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide Y receptor subtypes, Y1 and Y2.
Wahlestedt C; Grundemar L; Håkanson R; Heilig M; Shen GH; Zukowska-Grojec Z; Reis DJ
Ann N Y Acad Sci; 1990; 611():7-26. PubMed ID: 2174225
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Ca2+ channel currents in human neuroblastoma (SH-SY5Y) cells by neuropeptide Y and a novel cyclic neuropeptide Y analogue.
McDonald RL; Vaughan PF; Beck-Sickinger AG; Peers C
Neuropharmacology; 1995 Nov; 34(11):1507-14. PubMed ID: 8606797
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Y3 receptor-mediated synaptic inhibition by chimeric neuropeptide Y-peptide YY peptides in the rat brainstem.
Glaum SR; Miller RJ; Rhim H; Maclean D; Georgic LM; MacKenzie RG; Grundemar L
Br J Pharmacol; 1997 Feb; 120(3):481-7. PubMed ID: 9031753
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of Y receptors and signaling pathways in intestinal circular and longitudinal smooth muscle.
Misra S; Mahavadi S; Grider JR; Murthy KS
Regul Pept; 2005 Feb; 125(1-3):163-72. PubMed ID: 15582728
[TBL] [Abstract][Full Text] [Related]
13. A comparison of actions of neuropeptide Y (NPY) agonists and antagonists at NPY Y1 and Y2 receptors in anaesthetized rats.
Smith-White M; Moriarty MJ; Potter EK
Neuropeptides; 1998 Apr; 32(2):109-18. PubMed ID: 9639248
[TBL] [Abstract][Full Text] [Related]
14. Autoreceptor-induced inhibition of neuropeptide Y release from PC-12 cells is mediated by Y2 receptors.
Chen X; DiMaggio DA; Han SP; Westfall TC
Am J Physiol; 1997 Oct; 273(4):H1737-44. PubMed ID: 9362238
[TBL] [Abstract][Full Text] [Related]
15. Spinal modulation of duodenal and colonic motility and arterial pressure by neuropeptide Y, neuropeptide Y fragment 13-36, peptide YY, and pancreatic polypeptide in rats: involvement of the cholinergic nervous system.
Wager-Pagé SA; Raizada E; Veale WL; Davison JS
Can J Physiol Pharmacol; 1993 Feb; 71(2):112-9. PubMed ID: 8319134
[TBL] [Abstract][Full Text] [Related]
16. Regulation of neuropeptide Y release by neuropeptide Y receptor ligands and calcium channel antagonists in hypothalamic slices.
King PJ; Widdowson PS; Doods HN; Williams G
J Neurochem; 1999 Aug; 73(2):641-6. PubMed ID: 10428060
[TBL] [Abstract][Full Text] [Related]
17. Distribution of [Leu31,Pro34]NPY-sensitive, BIBP3226-insensitive [125I]PYY(3-36) binding sites in rat brain: possible relationship to Y5 NPY receptors.
Widdowson PS; Buckingham R; Williams G
Brain Res; 1997 Dec; 778(1):242-50. PubMed ID: 9462897
[TBL] [Abstract][Full Text] [Related]
18. Structure-function studies on neuropeptide Y and pancreatic polypeptide--evidence for two PP-fold receptors in vas deferens.
Jørgensen JC; Fuhlendorff J; Schwartz TW
Eur J Pharmacol; 1990 Sep; 186(1):105-14. PubMed ID: 2178092
[TBL] [Abstract][Full Text] [Related]
19. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.
Raposinho PD; Broqua P; Pierroz DD; Hayward A; Dumont Y; Quirion R; Junien JL; Aubert ML
Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275
[TBL] [Abstract][Full Text] [Related]
20. Different regulation of atrial ANP release through neuropeptide Y2 and Y4 receptors.
Piao FL; Yuan K; Bai GY; Han JH; Park WH; Kim SH
J Korean Med Sci; 2008 Dec; 23(6):1027-32. PubMed ID: 19119448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
